ESX Homeobox 1 antibody (Center)
Quick Overview for ESX Homeobox 1 antibody (Center) (ABIN499804)
Target
See all ESX Homeobox 1 (ESX1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Center
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- ESX1 antibody was raised against a 19 amino acid peptide near the center of human ESX1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: 1 - 2 μg/mL. Immunohistochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- ESX Homeobox 1 (ESX1)
-
Alternative Name
- ESX1
-
Background
- Homeobox proteins are transcription factors that contain a helix-turn-helix DNA binding domain termed the homeodomain. ESX1 is an X-linked homeobox gene primarily expressed in the placenta and testis and contains two functional domains: the homeodomain and the proline-rich domain. During embryogenesis, ESX1 is expressed in the extraembryonic tissues, including the endoderm of the visceral yolk sac, the ectoderm of the chorion and the labyrinthine trophoblast of the chorioallantoic placenta. ESX1 can act like a transcriptional repressor to the human oncogene K-ras and treatment of human cancer cells with an ESX1 protein fragment containing the homeodomain reduces the tumorgenicity of cells containing oncogenic K-ras mutations, suggesting ESX1 may be useful as a therapeutic treatment for these cancers.Synonyms: ESX1L, ESX1R, Homeobox protein ESX1
-
Gene ID
- 80712
-
UniProt
- Q8N693
Target
-